Exposure to the common stomach bug Helicobacter pylori may be linked to an estimated 22 percent of global colorectal cancer cases, according to an international research team. The mathematical modelling study, published in eGastroenterology, combined global infection figures with data from 43 prior studies involving nearly 49 million people.
A widespread bacterial infection behind common gastrointestinal bugs has drawn renewed scrutiny from medical researchers exploring the roots of bowel cancer. An international team of researchers co-led by academics at the University of Hong Kong and the University of California San Diego examined findings from extensive reviews of prior studies regarding germ exposure and bowel cancer. They paired these historical reviews with figures provided by the Global Cancer Observatory to build a comprehensive risk attribution model.
While Helicobacter pylori is already well-documented as a primary driver of stomach cancer, its connection to malignancies further down the digestive tract has long remained described as highly controversial by the scientific community. Up to two in five people in the UK alone carry the microbe within their digestive system, often contracting the infection during childhood via direct contact with an infected individual’s saliva, vomit, or stool. Although most infections remain asymptomatic, some patients develop ulcers or chronic inflammation along the stomach lining.
What the Mathematical Model and Global Data Reveal About Risk
The newly published analysis evaluated data across 43 separate studies encompassing nearly 49 million individuals. The researchers discovered that exposure to H. pylori correlates with a 1.59-fold increased risk of colorectal cancer when compared against unexposed populations. Under a strict causal assumption, the authors calculated that H. pylori exposure may be related to an estimated 22% of global CRC (colorectal cancer) cases.
However, independent experts reviewing the methodology emphasize that this top-tier estimate represents the absolute upper limit of what the calculation can produce. When the study authors adjusted their mathematical simulations to rely solely on the highest-quality investigations—restricting data to 14 population-based and cohort studies—the attributable proportion dropped significantly to 12 percent. This sharp decline underscores how sensitive broad epidemiological models are to the underlying strength of the evidence.
Expert Reactions and Methodological Limitations
Scientific reaction to the publication highlights both the innovative nature of the modelling and its inherent limitations. Because the paper relies on a mathematical simulation rather than a fresh clinical trial or new patient cohort, specialists caution against altering immediate clinical practices.
“This is a well-conducted piece of modelling. The researchers took an existing statistical link between H. pylori and bowel cancer risk and used it, together with global infection and cancer data, to estimate how much bowel cancer could theoretically be tied to the infection if that link turns out to be a genuine cause-and-effect relationship. That’s a big ‘if’, and it’s one the authors themselves are careful to flag.”
Photo: doctors.net.uk
Dr Rosiered Brownson-Smith, Colorectal Cancer Researcher, King’s College London
Echoing these cautions, Iago Rodríguez-Lago, a gastroenterologist at Galdakao-Usansolo University Hospital, pointed out that 38 of the 43 studies evaluated were case-control or cross-sectional designs, while only five were prospective cohorts. The wide disparity between those sources left the authors barely able to account for 7 percent of the statistical heterogeneity. Experts note that people carrying the bacterium often differ from non-carriers in socioeconomic status, diet, sanitation, and healthcare access—confounding factors that retrospective studies struggle to eliminate entirely.
Generational Shifts and the Question of Antibiotic Eradication
The study also broke down infection-linked bowel cancer proportions across different birth cohorts, evaluating individuals born before 1947, between 1948 and 1962, and from 1963 to 1977.
New colorectal cancer screening guidelines issued for high-risk Kentuckians
Researchers stress that confirming whether eradicating the bacterium actively prevents bowel cancer will require rigorous, prospective, long-term clinical trials. Until those trials yield results, the widespread stomach bug remains an intriguing target for future gastroenterological research rather than an immediate target for routine colorectal screening policy changes.
